Effect of AXOS on the Colon Metabolism in Healthy Volunteers
Phase 2
Completed
- Conditions
- Gut Health
- Registration Number
- NCT01656499
- Lead Sponsor
- KU Leuven
- Brief Summary
The purpose of this study is to evaluate the effect of AXOS on parameters of colon metabolism and gut health
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- healthy volunteers
- regular dietary pattern (3 meals/day)
- age: 18-45y
- BMI: 18,5-27 kg/m2
Exclusion Criteria
- intake of antibiotics 1 month prior to the study
- abdominal surgery in the past, with the exception of appendectomy
- intake of medication influencing the gastro-intestinal system 14 days prior to the study
- in treatment at a dietician
- serious liver- or kidney failure
- vegetarians
- intake of pre- and/or probiotics
- Exposure to radioactivity 1 year prior to the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Fecal water toxicity Participants are followed for 10 weeks, with measurements on 4 specific time points
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does AXOS influence in colon metabolism and gut health?
How does AXOS compare to other prebiotics in improving gut microbiota composition and SCFA production?
Which biomarkers are associated with AXOS-induced changes in colon health parameters?
What adverse events were observed in AXOS trials and how were they managed in healthy volunteers?
Are there combination therapies involving AXOS that enhance gut barrier function or reduce inflammation?
Trial Locations
- Locations (1)
UZ Leuven/KU Leuven
🇧🇪Leuven, Vlaams-Brabant, Belgium
UZ Leuven/KU Leuven🇧🇪Leuven, Vlaams-Brabant, Belgium